Acquisition of high-cost medication: Risankizumab Concentration: 60 MG/ML, Pharmaceutical Form: Quantity: 3 - Solution for Dilution for Infusion and Risankizumab Concentration: Quantity: 5 - 150 MG/ ML, Pharmaceutical Form: Injectable Solution, Caract
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Acquisition of high-cost medication: Risankizumab Concentration: 60 MG/ML, Pharmaceutical Form: Quantity: 3 - Solution for Dilution for Infusion and Risankizumab Concentration: Quantity: 5 - 150 MG/ ML, Pharmaceutical Form: Injectable Solution, Additional Features: Prefilled Syringe with Applicator Pen.
Related Procurement Opportunities
Similar tenders in Pharmaceuticals